/5
0 avis
Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
Archive ouverte
Edité par CCSD ; Sage Publishing -
International audience
Consulter en ligne
Chargement des enrichissements...